<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04869735</url>
  </required_header>
  <id_info>
    <org_study_id>2021-003-Info-Vac</org_study_id>
    <nct_id>NCT04869735</nct_id>
  </id_info>
  <brief_title>Impact of Information About Booster Vaccination Against DTPolio at 25 Years on This Booster Vaccination's Realization</brief_title>
  <acronym>Info-Vac</acronym>
  <official_title>Impact of Information About Booster Vaccination Against DTPolio at 25 Years on This Booster Vaccination's Realization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université de Reims Champagne-Ardenne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Université de Reims Champagne-Ardenne</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of vaccination is to protect the patient against disease by stimulating his immune&#xD;
      system. DTPolio is a tetravalent vaccine providing protection against pertussis, diphtheria,&#xD;
      tetanus and polio.&#xD;
&#xD;
      In France, the vaccination schedule sets the vaccination recommendations applicable to people&#xD;
      according to their age. In this schedule, a booster of DTPolio at the age of 25 is&#xD;
      recommended.&#xD;
&#xD;
      The vaccination coverage for patients over 16 years of age is insufficient in France.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to evaluate impact of information about booster vaccination against&#xD;
      DTPolio at 25 years on this booster vaccination's realization.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 4, 2021</start_date>
  <completion_date type="Anticipated">September 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>DTPolio vaccine delivery</measure>
    <time_frame>12 months</time_frame>
    <description>DTPolio vaccine delivery by pharmacies within 12 months of sending information about booster vaccination against DTPolio at 25 years</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">2125</enrollment>
  <condition>Vaccination</condition>
  <arm_group>
    <arm_group_label>With information about booster vaccination</arm_group_label>
    <description>Adults aged 25 years in 2020 without delivery of DTPolio vaccine in 2019 or 2020, to whom information concerning this vaccination is given</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Without information about booster vaccination</arm_group_label>
    <description>Adults aged 25 years in 2020 without delivery of DTPolio vaccine in 2019 or 2020, to whom information concerning this vaccination is not given.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data collection: DTPolio vaccine delivery</intervention_name>
    <description>&quot;with information about booster vaccination&quot; group: Sending of information concerning booster vaccination against DTPolio at 25 years using letters, emails and SMS &quot;without information about booster vaccination&quot; group: no intervention</description>
    <arm_group_label>With information about booster vaccination</arm_group_label>
    <arm_group_label>Without information about booster vaccination</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        People aged 25&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  aged 25 years old in 2020&#xD;
&#xD;
          -  without delivery of DTPolio vaccine in 2019 or 2020&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brigitte VUILLEMIN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université de Reims CHampahne-Ardenne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Brigitte VUILLEMIN</last_name>
    <phone>03 24 72 93 77</phone>
    <email>vuillemin0Ol@wanadoo.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Université de Reims Champagne-Ardenne</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brigitte VUILLEMIN</last_name>
      <phone>03 24 72 93 77</phone>
      <email>vuillemin0Ol@wanadoo.fr</email>
    </contact>
    <contact_backup>
      <last_name>Aline HURTAUD</last_name>
      <phone>06 86 52 46 44</phone>
      <email>aline.ohl-hurtaud@univ-reims.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 27, 2021</study_first_submitted>
  <study_first_submitted_qc>April 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 3, 2021</study_first_posted>
  <last_update_submitted>July 1, 2021</last_update_submitted>
  <last_update_submitted_qc>July 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Booster vaccination</keyword>
  <keyword>Adult</keyword>
  <keyword>Information</keyword>
  <keyword>DTPolio</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

